Amgen Slashes the Price of a Promising Cholesterol Drug

The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager. KATIE THOMAS https://ift.tt/2Sj05PK The New York Times Health Repatha (Drug), Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Praluent (Drug), Cholesterol October 25, 2018 at 12:00AM